Molecular Formula | C20H16N2OS |
Molar Mass | 332.42 |
Density | 1.32±0.1 g/cm3 (20 ºC 760 Torr) |
Melting Point | 88-90oC |
Boling Point | 486.8±45.0 °C(Predicted) |
Solubility | Soluble in DMSO (up to 13 mg/ml with warming) or in Ethanol (up to 4 mg/ml with warming) |
Appearance | Tan solid |
Color | Off-white |
pKa | 11.95±0.20(Predicted) |
Storage Condition | Keep in dark place,Sealed in dry,Room Temperature |
Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months. |
In vitro study | JNK inhibitor IX significantly reduces caspase-3 activity in human skin fibroblasts by inhibiting JNK activity JNK inhibitor IX-mediated inhibition of JNK by preventing complete dephosphorylation of c-ABL on serine residues, significantly increased apoptotic death after imatinib mesylate (IM) treatment. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.008 ml | 15.041 ml | 30.082 ml |
5 mM | 0.602 ml | 3.008 ml | 6.016 ml |
10 mM | 0.301 ml | 1.504 ml | 3.008 ml |
5 mM | 0.06 ml | 0.301 ml | 0.602 ml |
biological activity | JNK inhibitor IX (TCS JNK 5a) is a highly selective inhibitor of JNK, its pIC50 for JNK2 and JNK3 were 6.5 and 6.7, respectively. |
Target | Value |
JNK3 | 6.7(pIC50) |
JNK2 | 6.5(pIC50) |